Home › Funds › NEA Management Company, LLC › TRVI

NEA Management Company, LLC position in TRVI

TREVI THERAPEUTICS INC · Health Care

NEA Management Company, LLC reported holding 13,222,228 shares of TRVI (TREVI THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$246.6M, representing 15.53% of its reported portfolio and ranking #1 among its reported holdings. NEA Management Company, LLC has disclosed TRVI holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)13.22M sh
Reported value held$246.59M
Portfolio Weight15.53%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How NEA Management Company, LLC's TRVI position evolved

NEA Management Company, LLC first disclosed a stake in TRVI in Q3 2023 at 11,370,376 shares (US$24.8M). The position peaked in Q2 2026 at 13,222,228 shares, worth US$246.6M. Across 12 filings, NEA Management Company, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 13,222,228 shares valued at US$246.6M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 11.37M $24.79M New
Q4 2023 11.37M $15.24M Hold
Q1 2024 11.37M $39.23M Hold
Q2 2024 11.37M $33.88M Hold
Q3 2024 11.37M $37.98M Hold
Q4 2024 11.37M $48.85M Hold
Q1 2025 11.37M $71.52M Hold
Q2 2025 13.22M $72.33M Add
Q3 2025 13.22M $120.98M Hold
Q4 2025 13.22M $165.54M Hold
Q1 2026 13.22M $157.74M Hold
Q2 2026 13.22M $246.59M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TRVI and 13F data

TRVI (TREVI THERAPEUTICS INC) is a Health Care company. 64 other funds we track also report a position in TRVI — the largest reported positions include Frazier Life Sciences Management, L.P. (US$185.4M), Vivo Capital, LLC (US$95.0M), Vestal Point Capital, LP (US$57.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TRVI

All TRVI fund holders →

FAQ

How long has NEA Management Company, LLC held TRVI?

NEA Management Company, LLC has disclosed TRVI holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is NEA Management Company, LLC's current position in TRVI?

As of Q2 2026, NEA Management Company, LLC holds 13.22M shares of TRVI (TREVI THERAPEUTICS INC), valued at $246.59M, representing 15.53% of its reported portfolio and ranking #1.

Has NEA Management Company, LLC been buying or selling TRVI?

In the latest 13F filing (Q2 2026), NEA Management Company, LLC held unchanged its position in TRVI. The position peaked in Q2 2026 at 13.22M shares.

Which other funds hold TRVI?

Other major institutional holders of TRVI include Frazier Life Sciences Management, L.P., Vivo Capital, LLC, Vestal Point Capital, LP, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.